Going the Distance
Isentress comparable to Sustiva over five years of treatment.

Treatment as Prevention in People with HIV
Full results of the HPTN 052 study at IAS 2011 confirm ARVs reduce HIV risk by 96 percent for heterosexual couples.

Female Power
Genital secretions from women with HIV using ARVs contain high drug concentrations and low amounts of virus.

No Bones
About It
Traditional risk factors for fractures—race, aging, smoking and diabetes—are much greater contributors than HIV meds.

IAS in Rome
Check out the IAS 2011 website for a comprehensive roundup of the current conference.

Say What?
Hearing loss tied to age, gender, race; not HIV.

Truvada as
HIV Prevention
Preliminary data from the Partners PrEP study at IAS 2011 "definitively" show reduced HIV risk for mixed-status heterosexual couples.

Early Treatment Reduces Serious Illness
Starting ARVs once a CD4 count falls below 550 was associated with a 40 percent reduction in the risk of serious illness in HPTN 052.

Science Only Half the Battle
IAS 2011 organizers warn discoveries only matter if they can effectively be rolled out evenly across the world.

IAS Journal
The Journal of the International AIDS Society provides a forum for HIV-related research.

A Shore Thing
Testing for HIV in NJ emergency rooms works.

Strategy for
the Cure
IAS 2011 leadership calls for accelerated research toward a cure for HIV—and they want your help.

Racking
Your Brain
Drugs known to penetrate the central nervous system do not offer much more protection against neuropsychological problems associated with HIV.

Transplant Survival
Survival is "excellent" among people living with HIV undergoing kidney transplants.

DC in 2012
For updates on the next International AIDS Conference in Washington, DC, go to the AIDS 2012 website.